BACKGROUND
In the absence of an ideal treatment for chronic pain associated with rheumatic diseases, there is interest in the potential effects of cannabinoid molecules, particularly in the context of global interest in the legalization of herbal cannabis for medicinal use.
METHODS
A systematic
This study sought to characterize the real-world treatment of chronic noncancer pain (CNCP) in patients on opioid therapy in primary care.A retrospective cohort study from 2014-18 was conducted at a multidisciplinary primary care clinic in Chilliwack,